ReP USP - Resultado da busca

Artigo de periodico
Interleukin-23 promotes intestinal T helper type17 immunity and ameliorates obesity-associated metabolic syndrome in a murine high-fat diet model (2018)
Martins, Larissa M. S.; Perez, Malena M.; Pereira, Camila A.; Costa, Frederico R. C.; Dias, Murilo S.; Tostes, Rita de Cássia Aleixo; Ramos, Simone Gusmão; Zoete, Marcel R. de; Ryffel, Bernhard; Silva, João Santana da; Carlos, Daniela
Source: Immunology. Unidade: FMRP
Subjects: INFLAMAÇÃO, LINFÓCITOS, INTERLEUCINAS, DOENÇAS METABÓLICAS, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, Larissa M. S. et al. Interleukin-23 promotes intestinal T helper type17 immunity and ameliorates obesity-associated metabolic syndrome in a murine high-fat diet model. Immunology, v. 154, n. 4, p. 624-636, 2018Tradução . . Disponível em: https://doi.org/10.1111/imm.12946. Acesso em: 03 nov. 2024.
APA
Martins, L. M. S., Perez, M. M., Pereira, C. A., Costa, F. R. C., Dias, M. S., Tostes, R. de C. A., et al. (2018). Interleukin-23 promotes intestinal T helper type17 immunity and ameliorates obesity-associated metabolic syndrome in a murine high-fat diet model. Immunology, 154( 4), 624-636. doi:10.1111/imm.12946
NLM
Martins LMS, Perez MM, Pereira CA, Costa FRC, Dias MS, Tostes R de CA, Ramos SG, Zoete MR de, Ryffel B, Silva JS da, Carlos D. Interleukin-23 promotes intestinal T helper type17 immunity and ameliorates obesity-associated metabolic syndrome in a murine high-fat diet model [Internet]. Immunology. 2018 ; 154( 4): 624-636.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1111/imm.12946
Vancouver
Martins LMS, Perez MM, Pereira CA, Costa FRC, Dias MS, Tostes R de CA, Ramos SG, Zoete MR de, Ryffel B, Silva JS da, Carlos D. Interleukin-23 promotes intestinal T helper type17 immunity and ameliorates obesity-associated metabolic syndrome in a murine high-fat diet model [Internet]. Immunology. 2018 ; 154( 4): 624-636.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1111/imm.12946
Artigo de periodico
NLRP3 inflammasome: From pathogenesis to therapeutic strategies in Type 1 Diabetes (2017)
Carlos, Daniela; Costa, Frederico R. C.; Leite, Jefferson A.; André, Camila A.; Tostes, Rita de Cássia Aleixo; Carneiro, Fernando Silva; Câmara, Niels Olsen Saraiva ; Silva, João Santana da
Source: Journal of Autoimmune Disorders. Unidade: FMRP
Subjects: DIABETES MELLITUS, INSULINA, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARLOS, Daniela et al. NLRP3 inflammasome: From pathogenesis to therapeutic strategies in Type 1 Diabetes. Journal of Autoimmune Disorders, v. 3, n. 2, 2017Tradução . . Disponível em: https://doi.org/10.21767/2471-8513.100033. Acesso em: 03 nov. 2024.
APA
Carlos, D., Costa, F. R. C., Leite, J. A., André, C. A., Tostes, R. de C. A., Carneiro, F. S., et al. (2017). NLRP3 inflammasome: From pathogenesis to therapeutic strategies in Type 1 Diabetes. Journal of Autoimmune Disorders, 3( 2). doi:10.21767/2471-8513.100033
NLM
Carlos D, Costa FRC, Leite JA, André CA, Tostes R de CA, Carneiro FS, Câmara NOS, Silva JS da. NLRP3 inflammasome: From pathogenesis to therapeutic strategies in Type 1 Diabetes [Internet]. Journal of Autoimmune Disorders. 2017 ; 3( 2):[citado 2024 nov. 03 ] Available from: https://doi.org/10.21767/2471-8513.100033
Vancouver
Carlos D, Costa FRC, Leite JA, André CA, Tostes R de CA, Carneiro FS, Câmara NOS, Silva JS da. NLRP3 inflammasome: From pathogenesis to therapeutic strategies in Type 1 Diabetes [Internet]. Journal of Autoimmune Disorders. 2017 ; 3( 2):[citado 2024 nov. 03 ] Available from: https://doi.org/10.21767/2471-8513.100033
Artigo de periodico
Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset (2016)
Costa, Frederico R. C.; Françozo, Marcela C. S.; Oliveira, Gabriela G. de; Ignacio, Aline; Castoldi, Angela; Zamboni, Dario Simões; Ramos, Simone Gusmão; Câmara, Niels Olsen Saraiva ; Zoete, Marcel R. de; Palm, Noah W.; Flavell, Richard A.; Silva, João Santana da; Carlos, Daniela
Source: Journal of Experimental Medicine. Unidades: FMRP, ICB
Subjects: DIABETES MELLITUS, INTESTINOS, BACTÉRIAS, PROTEÍNAS, DOENÇAS AUTOIMUNES, SISTEMA IMUNE, PÂNCREAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Frederico R. C. et al. Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset. Journal of Experimental Medicine, v. 213, n. 7, p. 1223-1239, 2016Tradução . . Disponível em: https://doi.org/10.1084/jem.20150744. Acesso em: 03 nov. 2024.
APA
Costa, F. R. C., Françozo, M. C. S., Oliveira, G. G. de, Ignacio, A., Castoldi, A., Zamboni, D. S., et al. (2016). Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset. Journal of Experimental Medicine, 213( 7), 1223-1239. doi:10.1084/jem.20150744
NLM
Costa FRC, Françozo MCS, Oliveira GG de, Ignacio A, Castoldi A, Zamboni DS, Ramos SG, Câmara NOS, Zoete MR de, Palm NW, Flavell RA, Silva JS da, Carlos D. Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset [Internet]. Journal of Experimental Medicine. 2016 ; 213( 7): 1223-1239.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1084/jem.20150744
Vancouver
Costa FRC, Françozo MCS, Oliveira GG de, Ignacio A, Castoldi A, Zamboni DS, Ramos SG, Câmara NOS, Zoete MR de, Palm NW, Flavell RA, Silva JS da, Carlos D. Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset [Internet]. Journal of Experimental Medicine. 2016 ; 213( 7): 1223-1239.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1084/jem.20150744

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em